Literature DB >> 18444788

Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine.

Serena Barachini1, Luisa Trombi, Serena Danti, Delfo D'Alessandro, Barbara Battolla, Annalisa Legitimo, Claudia Nesti, Ilaria Mucci, Mario D'Acunto, Maria G Cascone, Luigi Lazzeri, Letizia Mattii, Rita Consolini, Mario Petrini.   

Abstract

Mesenchymal stem cells (MSCs) represent a promising source of progenitor cells having the potential to repair and to regenerate diseased or damaged skeletal tissues. Bone marrow (BM) has been the first source reported to contain MSCs. However, BM-derived cells are not always acceptable, due to the highly invasive drawing and the decline in MSC number and differentiative capability with increasing age. Human umbilical cord blood (UCB), obtainable by donation with a noninvasive method, has been introduced as an alternative source of MSCs. Here human UCB-derived MSCs isolation and morpho-functional characterization are reported. Human UCB-derived mononuclear cells, obtained by negative immunoselection, exhibited either an osteoclast-like or a mesenchymal-like phenotype. However, we were able to obtain homogeneous populations of MSCs that displayed a fibroblast-like morphology, expressed mesenchym-related antigens and showed differentiative capacities along osteoblastic and early chondroblastic lineages. Furthermore, this study is one among a few papers investigating human UCB-derived MSC growth and differentiation on three-dimensional scaffolds focusing on their potential applications in regenerative medicine and tissue engineering. UCB-derived MSCs were proved to grow on biodegradable microfiber meshes; additionally, they were able to differentiate toward mature osteoblasts when cultured inside human plasma clots, suggesting their potential application in orthopedic surgery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18444788     DOI: 10.1089/scd.2008.0017

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  15 in total

1.  A dose-dependent function of follicular fluid on the proliferation and differentiation of umbilical cord mesenchymal stem cells (MSCs) of goat.

Authors:  Pubin Qiu; Yaofu Bai; Chao Liu; Xin He; Hui Cao; Mingzhao Li; Haijing Zhu; Jinlian Hua
Journal:  Histochem Cell Biol       Date:  2012-06-10       Impact factor: 4.304

2.  Umbilical cord as a mesenchymal stem cell source for treating joint pathologies.

Authors:  Maria Carmen Arufe; Alexandre De la Fuente; Isaac Fuentes; Francisco Javier De Toro; Francisco Javier Blanco
Journal:  World J Orthop       Date:  2011-06-18

3.  Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro.

Authors:  Hao-Ping Sun; Xi Zhang; Xing-Hua Chen; Cheng Zhang; Lei Gao; Yi-Mei Feng; Xian-Gui Peng; Li Gao
Journal:  Stem Cells Dev       Date:  2011-12-05       Impact factor: 3.272

4.  Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood- and bone marrow-derived progenitors.

Authors:  Maria Antonietta Avanzini; Maria Ester Bernardo; Angela Maria Cometa; Cesare Perotti; Nadia Zaffaroni; Francesca Novara; Livia Visai; Antonia Moretta; Claudia Del Fante; Raffaella Villa; Lynne M Ball; Willem E Fibbe; Rita Maccario; Franco Locatelli
Journal:  Haematologica       Date:  2009-09-22       Impact factor: 9.941

5.  Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells.

Authors:  Simi M Chacko; Mahmood Khan; M Lakshmi Kuppusamy; Ramasamy P Pandian; Saradhadevi Varadharaj; Karuppaiyah Selvendiran; Anna Bratasz; Brian K Rivera; Periannan Kuppusamy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

6.  Study of the involvement of allogeneic MSCs in bone formation using the model of transgenic mice.

Authors:  Daria Kuznetsova; Natalia Prodanets; Svetlana Rodimova; Evgeny Antonov; Aleksandra Meleshina; Peter Timashev; Elena Zagaynova
Journal:  Cell Adh Migr       Date:  2016-06-17       Impact factor: 3.405

7.  Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment.

Authors:  Stefano Giannotti; Luisa Trombi; Vanna Bottai; Marco Ghilardi; Delfo D'Alessandro; Serena Danti; Giacomo Dell'Osso; Giulio Guido; Mario Petrini
Journal:  PLoS One       Date:  2013-08-30       Impact factor: 3.240

Review 8.  Deterministic and stochastic approaches in the clinical application of mesenchymal stromal cells (MSCs).

Authors:  Simone Pacini
Journal:  Front Cell Dev Biol       Date:  2014-09-12

9.  Mesangiogenic Progenitor Cells Are Tissue Specific and Cannot Be Isolated From Adipose Tissue or Umbilical Cord Blood.

Authors:  Serena Barachini; Marina Montali; Francesca M Panvini; Vittoria Carnicelli; Gian Luca Gatti; Nicola Piolanti; Enrico Bonicoli; Michelangelo Scaglione; Gabriele Buda; Paolo D Parchi
Journal:  Front Cell Dev Biol       Date:  2021-07-05

10.  Biological, functional and genetic characterization of bone marrow-derived mesenchymal stromal cells from pediatric patients affected by acute lymphoblastic leukemia.

Authors:  Antonella Conforti; Simone Biagini; Francesca Del Bufalo; Pietro Sirleto; Adriano Angioni; Nadia Starc; Giuseppina Li Pira; Francesca Moretta; Alessandra Proia; Benedetta Contoli; Silvia Genovese; Claudia Ciardi; Maria Antonietta Avanzini; Vittorio Rosti; Francesco Lo-Coco; Franco Locatelli; Maria Ester Bernardo
Journal:  PLoS One       Date:  2013-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.